Investing in Volatile Health Sectors

This chapter focuses on investment strategies within the high-risk health care and biotech industries, emphasizing patient investing during stock dips. Speakers analyze specific companies like Lilly, Amgen, and Bristol Myers, discussing their market performances and the importance of assessing future potentials and company pipelines.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app